Dyadic Applied BioSolutions

Dyadic to Present at Investor Conferences and BPI

Dyadic to Present at Investor Conferences and BPI East - Dyadic JUPITER, Fla., Sept. 04, 2025 (GLOBE NEWSWIRE) — Dyadic International, Inc., d/b/a Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (Nasdaq: DYAI), a global biotechnology company focused on the scalable production of high-value, precision engineered f...

Dyadic reports that it has developed fungal cell cultures that can outperform conventional cell cultures in the production of biologics

Dyadic International, Inc. (NASDAQ: DYAI) CEO Mark Emalfarb's interview with Gail Dutton of GEN (Genetic Engineering & Biotechnology News)

Fungal Cell Cultures Bloom with Benefits for Manufacturers Dyadic reports that it has developed fungal cell cultures that can outperform conventional cell cultures in the production of biologics.

Making Vaccine and Biotherapeutic Production Fast and Affordable
https://thebioreport.podbean.com/e/making-vaccine-and-biotherapeutic-production-fast-and-affordable/